Alkaline Water Expands CBD-Infused Product Line, Secures Supply
Robin Lefferts
September 11th, 2019
App, Exclusive, News, Top News
Cannabidiol (CBD) is the main active ingredient in cannabis that doesn’t get you high. Due to a wide range of potential health benefits, CBD-infused products have become quite the rage over the last few years. With the United States’ federal government delisting hemp, and hemp-derived CBD, in last fall’s 2018 Farm Bill, individual states across the nation have been formulating rules and regulations around CBD products. The new regulatory environment has spurred both public interest in the products and corporate interest in developing and distributing CBD.
As with any gold-rush-style industry boom, there are young upstarts, more established companies with industry expertise, and entrenched companies looking to buy their way into a hot market. Over the last couple of years, the wider cannabis industry has seen some of these dynamics in play with established producers buying niche brands, and multinational beverage companies investing in cannabis drink initiatives.
The Alkaline Water Company Inc. (NASDAQ: WTER) (TSXV: WTER) lies squarely in the middle of these dynamics. Alkaline Water’s flagship bottled water product, Alkaline 88®, has been driving impressive revenue growth for the company over the past few years as it cemented an extensive nationwide distribution footprint. With enhanced beverages (flavored, functional, etc.) becoming more and more popular, the company hatched a wholly-owned subsidiary called the A88 Infused Beverage Division. Recent developments show the company’s commitment to fast-tracking CBD-infused product introductions as soon as regulations allow.
Click here to see the company corporate presentation
CBD Supply Deal and New Products
Alkaline Water recently announced a CBD oil supply agreement with Centuria Foods. Centuria has been producing high quality, hemp derived CBD oil since 2014, a long time ago in this industry. Importantly, the oil provided to Alkaline Water has the advantage of being water soluble. Without getting too much into the science, CBD oil is generally not soluble in water but only soluble in lipids, or fats. This leads to all sorts of issues regarding bioavailability of the active CBD ingredient when ingested, as the human liver filters out much of the oil before letting it enter the bloodstream. The bloodstream is, of course, a water-based environment. So making the CBD oil water soluble ensures the delivery of a much higher concentration of the active ingredient, which is the point of buying CBD beverages in the first place.
Ensuring such a supply has spurred Alkaline Water to ramp up its CBD-infused product offerings. The company had already developed a line of CBD water under the brand name Soothe, and is now developing an array of CBD infused beverage shots alongside CBD tinctures, capsules, and powder packs.
The company has moved aggressively over the past year or so into the convenience store distribution channel, distinguished from its extensive box store and grocery chain channels. Alkaline Water views convenience stores as a natural fit for its new CBD products. “We are excited to announce the continued expansion of our CBD product portfolio. According to BDS Analytics, U.S. CBD sales are expected to surpass $20 billion by 2024.We expect to capitalize on this growth through leveraging our CBD product portfolio to accelerate our entrance into the convenience store market which has been an early adopter of ingestible CBD infused products,” stated Richard A. Wright, President and CEO of The Alkaline Water Company, Inc.
Click here to see the company corporate presentation
The Investment Environment
The mixing of the beverage/food and cannabis worlds has been pronounced over the last year or so. With Canada set to legalize cannabis-derived products (like beverages, topical creams, extract-based formulations) later this year, there have been deals and negotiations surrounding the space. Constellation Brands, maker of alcohol brands like Corona, Negro Modelo, and Black Velvet Canadian Whisky, famously poured C$5 billion into Canopy Growth back in November, 2018. Diageo, maker of brands like Guiness and Smirnoff, has been rumored to be in talks with cannabis companies and its CEO recently stated the company is looking at the sector. Coca-Cola had been rumored to be in talks about an investment or partnership but has since stated it currently has no intention of entering the market. PepsiCo’s CFO stated the company considers cannabis to be on the table on the same day the company said it is not entering the market.
Those potential deals are all of the partnership or investment kind. In a different vein, Mondelez International announced the company is considering CBD-infused versions of snack staples like Chips Ahoy, Nilla Wafers, and Cadbury chocolate. It may have to wait a bit longer.
In the United States, the Food & Drug Administration released an update on its approach to cannabinoids, including CBD, in food products. In part, “The U.S. Food and Drug Administration (FDA) recognizes the significant public interest in cannabis and cannabis-derived compounds, particularly CBD. However, there are many unanswered questions about the science, safety, and quality of products containing CBD. The Agency is working on answering these questions through ongoing efforts including feedback from a recent FDA hearing and information and data gathering through a public docket.”
Click here to see the company corporate presentation
The update indicates the body is actively working toward a regulatory framework but cautions specifically about making claims of medical benefit from CBD. So, though the Farm Bill removed hemp from the list of dangerous drugs and many states have since passed regulations allowing for the production of hemp, there is still a bit of wait-and-see going on in the US market.
Alkaline Water is laying the groundwork for immediate nationwide market entry now, developing a full line of products that can be easily introduced through its existing distribution network once the products gain approval. Considering Alkaline Water’s strong revenue and sales growth over the past several years, such a move could be a major boon for the company considering all of the market dynamics discussed here.
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Robin Lefferts
Robin Lefferts has been involved in the legal cannabis industry since 2012, sometimes as an active participant and always as an interested observer.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
The Yield Growth Corp. is a diverse team of business executives dedicated to rapid, sustainable financial growth for businesses with viable models for success.
Xphyto Therapeutics Corp. was created to bridge the gap between traditional cannabis-based medicine and modern scientific approaches to therapeutic validation.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
